Pamidronate therapy in children with osteogenesis imperfecta: Effect on the bone material level.

被引：0
|
作者：
Weber, M
Roschger, P
Rauch, F
Schoeberl, T
Fratzl-Zelman, N
Glorieux, FH
Fratzl, P
Klaushofer, K
机构：
[1] Hanusch Hosp, Ludwig Boltzmann Inst Osteol, Dept Med 4, Vienna, Austria
[2] UKH Meidling, Vienna, Austria
[3] Shriners Hosp Children, Genet Unit, Montreal, PQ, Canada
[4] McGill Univ, Montreal, PQ, Canada
[5] Univ Leoben, Erich Schmid Inst Mat Sci, Austrian Acad Sci, Leoben, Austria
[6] Univ Leoben, Inst Met Phys, Leoben, Austria
[7] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [1] Effect of Pamidronate Therapy in Children with Osteogenesis Imperfecta
    Baddouh, Naima
    Bourkhisi, L.
    Mghar, S.
    Lagrine, M.
    Ouayad, A.
    Nassih, H.
    Bourrahouat, A.
    Sab, I. Ait
    EUROPEAN JOURNAL OF PEDIATRICS, 2019, 178 (11) : 1686 - 1686
  • [2] Therapy with pamidronate in children with osteogenesis imperfecta
    Marginean, Otilia
    Tamasanu, Raluca Corina
    Mang, Niculina
    Mozos, Ioana
    Brad, Giorgiana Flavia
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2507 - 2515
  • [3] Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta
    Land, Christof
    Rauch, Frank
    Montpetit, Kathleen
    Ruck-Gibis, Joanne
    Glorieux, Francis H.
    JOURNAL OF PEDIATRICS, 2006, 148 (04): : 456 - 460
  • [4] Cyclic pamidronate therapy in children with osteogenesis imperfecta
    Salehpour, S.
    Rajaii, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 154 - 154
  • [5] Cyclic pamidronate therapy in children with Osteogenesis imperfecta
    Salehpour, Shadab
    Tavakkoli, Saeed
    HORMONE RESEARCH, 2008, 70 : 48 - 49
  • [6] Cyclic Pamidronate Therapy in Children with Osteogenesis Imperfecta
    Salehpour, S.
    Tavakkoli, S.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2010, 23 (1-2): : 73 - 80
  • [7] Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate therapy
    Rauch, F
    Plotkin, H
    Zeitlin, L
    Glorieux, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (04) : 610 - 614
  • [8] Osteogenesis imperfecta. Effect of Pamidronate therapy
    Pasqualini, T
    Galich, AM
    Plantalech, L
    BONE, 2005, 37 (01) : 133 - 133
  • [9] Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta
    Lowing, Kristina
    Astrom, Eva
    Oscarsson, Katarina Allbrink
    Soderhall, Stefan
    Eliasson, Ann-Christin
    ACTA PAEDIATRICA, 2007, 96 (08) : 1180 - 1183
  • [10] Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta
    Weber, Markus
    Roschger, Paul
    Fratzl-Zelman, Nadja
    Schoeberl, Thomas
    Rauch, Frank
    Glorieux, Francis H.
    Fratzl, Peter
    Klaushofer, Klaus
    BONE, 2006, 39 (03) : 616 - 622
12345